BHVN
Price
$20.37
Change
+$1.69 (+9.05%)
Updated
Apr 17 closing price
Capitalization
2.08B
21 days until earnings call
TVTX
Price
$14.92
Change
+$0.35 (+2.40%)
Updated
Apr 17 closing price
Capitalization
1.32B
13 days until earnings call
Ad is loading...

BHVN vs TVTX

Header iconBHVN vs TVTX Comparison
Open Charts BHVN vs TVTXBanner chart's image
Biohaven
Price$20.37
Change+$1.69 (+9.05%)
Volume$2.1M
Capitalization2.08B
Travere Therapeutics
Price$14.92
Change+$0.35 (+2.40%)
Volume$1.1M
Capitalization1.32B
BHVN vs TVTX Comparison Chart
Loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHVN vs. TVTX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHVN is a Hold and TVTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 18, 2025
Stock price -- (BHVN: $20.37 vs. TVTX: $14.92)
Brand notoriety: BHVN and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BHVN: 158% vs. TVTX: 58%
Market capitalization -- BHVN: $2.08B vs. TVTX: $1.32B
BHVN [@Biotechnology] is valued at $2.08B. TVTX’s [@Biotechnology] market capitalization is $1.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHVN’s FA Score shows that 0 FA rating(s) are green whileTVTX’s FA Score has 0 green FA rating(s).

  • BHVN’s FA Score: 0 green, 5 red.
  • TVTX’s FA Score: 0 green, 5 red.
According to our system of comparison, TVTX is a better buy in the long-term than BHVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHVN’s TA Score shows that 5 TA indicator(s) are bullish while TVTX’s TA Score has 4 bullish TA indicator(s).

  • BHVN’s TA Score: 5 bullish, 3 bearish.
  • TVTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BHVN is a better buy in the short-term than TVTX.

Price Growth

BHVN (@Biotechnology) experienced а +18.91% price change this week, while TVTX (@Biotechnology) price change was +10.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

BHVN is expected to report earnings on Aug 04, 2025.

TVTX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHVN($2.08B) has a higher market cap than TVTX($1.32B). TVTX YTD gains are higher at: -14.351 vs. BHVN (-45.462). TVTX has higher annual earnings (EBITDA): -265.77M vs. BHVN (-877.26M). BHVN has more cash in the bank: 486M vs. TVTX (371M). BHVN has less debt than TVTX: BHVN (36.6M) vs TVTX (402M). TVTX has higher revenues than BHVN: TVTX (233M) vs BHVN (0).
BHVNTVTXBHVN / TVTX
Capitalization2.08B1.32B157%
EBITDA-877.26M-265.77M330%
Gain YTD-45.462-14.351317%
P/E RatioN/AN/A-
Revenue0233M-
Total Cash486M371M131%
Total Debt36.6M402M9%
FUNDAMENTALS RATINGS
BHVN vs TVTX: Fundamental Ratings
BHVN
TVTX
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
85
Overvalued
PROFIT vs RISK RATING
1..100
10085
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
9557
P/E GROWTH RATING
1..100
10038
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHVN's Valuation (54) in the Pharmaceuticals Major industry is in the same range as TVTX (85) in the Biotechnology industry. This means that BHVN’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's Profit vs Risk Rating (85) in the Biotechnology industry is in the same range as BHVN (100) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew similarly to BHVN’s over the last 12 months.

BHVN's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as TVTX (98) in the Biotechnology industry. This means that BHVN’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's Price Growth Rating (57) in the Biotechnology industry is somewhat better than the same rating for BHVN (95) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew somewhat faster than BHVN’s over the last 12 months.

TVTX's P/E Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for BHVN (100) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew somewhat faster than BHVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHVNTVTX
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
73%
Bearish Trend 15 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
BHVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIEIX36.72N/A
N/A
Nuveen Equity Index R6
CHTTX18.76N/A
N/A
AMG River Road Mid Cap Value N
APGRX17.45N/A
N/A
Yorktown Growth Institutional
HFDTX17.29N/A
N/A
Hartford Schroders US MidCap Opps R5
FITFX13.43N/A
N/A
Fidelity Flex International Index

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with CGON. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
+9.05%
CGON - BHVN
49%
Loosely correlated
+2.08%
OCUL - BHVN
48%
Loosely correlated
+1.95%
XENE - BHVN
47%
Loosely correlated
+3.94%
RCKT - BHVN
47%
Loosely correlated
+2.93%
IOVA - BHVN
46%
Loosely correlated
-0.33%
More

TVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with CRNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
+2.40%
CRNX - TVTX
41%
Loosely correlated
+2.84%
BHVN - TVTX
41%
Loosely correlated
+9.05%
COGT - TVTX
39%
Loosely correlated
+2.34%
RLAY - TVTX
39%
Loosely correlated
+3.07%
XNCR - TVTX
39%
Loosely correlated
+1.89%
More